ImageneBio (IMA) EBIT (QoQ) (2020 - 2025)
ImageneBio (IMA) EBIT (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - |
| 10 | ImageneBio | 48.35 Mn | -87.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -203.93% |
| Jun 30, 2025 | -45.95% |
| Mar 31, 2025 | 78.68% |
| Dec 31, 2024 | -1,280.89% |
| Sep 30, 2024 | 87.13% |
| Jun 30, 2024 | 13.18% |
| Mar 31, 2024 | 16.81% |
| Dec 31, 2023 | -12.33% |
| Sep 30, 2023 | -5.48% |
| Jun 30, 2023 | -19.17% |
| Mar 31, 2023 | -2.65% |
| Dec 31, 2022 | 15.45% |
| Sep 30, 2022 | 14.68% |
| Jun 30, 2022 | -23.52% |
| Mar 31, 2022 | -707.52% |
| Dec 31, 2021 | 119.23% |
| Sep 30, 2021 | -14.46% |
| Jun 30, 2021 | -30.52% |
| Mar 31, 2021 | 62.69% |
| Dec 31, 2020 | -317.98% |